This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Polycythemia vera: The natural history of 1213 patients followed for 20 years. Gruppo italiano studio policitemia. Ann Intern Med. 1995; 123(9): 656-664.Polycythemia vera: The natural history of 1213 patients followed for 20 years. Gruppo italiano studio policitemiaAnn Intern Med.19951239656664Search in Google Scholar
Cortelazzo S, Viero P, Finazzi G, D’Emilio A, Rodeghiero F, Barbui T. Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. J Clin Oncol. 1990; 8(3): 556-562.CortelazzoSVieroPFinazziGD’EmilioARodeghieroFBarbuiT.Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemiaJ Clin Oncol.199083556562Search in Google Scholar
Barbui T, Carobbio A, Cervantes F, Vannucchi AM, Glglielmelli P, Antonioli E, et al.Thrombosis in primary myelofibrosis: Incidence and risk factors. Blood. 2010; 115(4): 778-782.BarbuiTCarobbioACervantesFVannucchiAMGlglielmelliPAntonioliEThrombosis in primary myelofibrosis: Incidence and risk factorsnBlood.20101154778782Search in Google Scholar
Passamonti F, Rumi E, Pungolino E, Malabarba L, Bertazzoni P, Valentini M, et al. Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia. Am J Med. 2004; 117(10): 755-761.PassamontiFRumiEPungolinoEMalabarbaLBertazzoniPValentiniMLife expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemiaAm J Med.200411710755761Search in Google Scholar
Watson KV, Key N. Vascular complications of essential thrombocythaemia: A link to cardiovascular risk factors. Br J Haematol. 1993; 83(2): 198-203.WatsonKVKeyN.Vascular complications of essential thrombocythaemia: A link to cardiovascular risk factorsBr J Haematol.1993832198203Search in Google Scholar
Barbui T, Thiele J, Passamonti F, Rumi E, Boveri E, Ruggeri M, et al. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: An international study. J Clin. Oncol. 2011; 29(23): 3179-3184.BarbuiTThieleJPassamontiFRumiEBoveriERuggeriMSurvival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: An international studyJ Clin. Oncol.2011292331793184Search in Google Scholar
Enblom A, Lindskog E, Hasselbalch H, Hersby D, Bak M, Tetu J, et al. High rate of abnormal blood values and vascular complications before diagnosis of myelopro-liferative neoplasms. Eur J Intern Med. 2015; 26(5): 344-347.EnblomALindskogEHasselbalchHHersbyDBakMTetuJHigh rate of abnormal blood values and vascular complications before diagnosis of myelopro-liferative neoplasmsEur J Intern Med.2015265344347Search in Google Scholar
Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD, et al. Somatic mutations of cal-reticulin in myeloproliferative neoplasms. N Engl J Med. 2013; 369(25): 2379-2390.KlampflTGisslingerHHarutyunyanASNivarthiHRumiEMilosevicJDSomatic mutations of cal-reticulin in myeloproliferative neoplasmsN Engl J Med.20133692523792390Search in Google Scholar
Nangalia J, Massie CE, Baxter EJ, Nice FL, Gundem G, Wedge DC, et al. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med. 2013; 369(25): 2391-2405.NangaliaJMassieCEBaxterEJNiceFLGundemGWedgeDCSomatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2N Engl J Med.20133692523912405Search in Google Scholar
Fleischman AG, Tyner JW. Causal role for JAK2 V617F in thrombosis. Blood. 2013; 122(23): 3705-3706.FleischmanAGTynerJW.Causal role for JAK2 V617F in thrombosisBlood.20131222337053706Search in Google Scholar
Tefferi A, Thiele J, Vannucchi AM, Barbui T. An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms. Leukemia. 2014; 28(7): 1407-1413.TefferiAThieleJVannucchiAMBarbuiT.An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasmsLeukemia.201428714071413Search in Google Scholar
Peerschke EIB, Lopez JA. Platelet membranes and receptors. In: Loscalzo J, Schafer AI, Eds. Thrombosis and Hemorrhage, 2nd ed. Baltimore, MD, USA: Williams and Wilkins. 1998: 229-260.PeerschkeEIBLopezJA.Platelet membranes and receptorsLoscalzoJSchaferAIThrombosis and Hemorrhage2ndBaltimore, MD, USAWilliams and Wilkins1998229260Search in Google Scholar
Andrews RK, Shen Y, Gardiner EE, Dong JF, Lopez JA, Berndt MC. The glycoprotein ib-IX-V complex in platelet adhesion and signaling. Thromb Haemost. 1999; 82(2): 357-364.AndrewsRKShenYGardinerEEDongJFLopezJABerndtMC.The glycoprotein ib-IX-V complex in platelet adhesion and signalingThromb Haemost.1999822357364Search in Google Scholar
Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002; 8(11): 1227-1234.RuggeriZM.Platelets in atherothrombosisNat Med.200281112271234Search in Google Scholar
Ruggeri ZM. New insights into the mechanisms of platelet adhesion and aggregation. Semin Hematol. 1994; 31(3): 229-239.RuggeriZM.New insights into the mechanisms of platelet adhesion and aggregationSemin Hematol.1994313229239Search in Google Scholar
Afshar-Kharghan V, Lopez JA, Gray LA, Padilla A, Borthakur G, Roberts SC, et al. Hemostatic gene poly-morphisms and the prevalence of thrombotic complications in polycythemia vera and essential thrombocythemia. Blood Coagul Fibrinolysis. 2004; 15(1): 21-24.Afshar-KharghanVLopezJAGrayLAPadillaABorthakurGRobertsSCHemostatic gene poly-morphisms and the prevalence of thrombotic complications in polycythemia vera and essential thrombocythemiaBlood Coagul Fibrinolysis.20041512124Search in Google Scholar
Hoffman M, Colina CM, McDonald AG, Arepally GM, Pedersen L, Monroe DM. Tissue factor around dermal vessels has bound factor VII in the absence of injury. J Thromb Haemost. 2007; 5(7): 1403-1408.HoffmanMColinaCMMcDonaldAGArepallyGMPedersenLMonroeDM.Tissue factor around dermal vessels has bound factor VII in the absence of injuryJ Thromb Haemost.20075714031408Search in Google Scholar
Buxhofer-Ausch V, Olcaydu D, Gisslinger B, Schalling M, Frantal S, Thiele J, et al. Decanucleotide insertion polymorphism of F7 significantly influences the risk of thrombosis in patients with essential thrombocythemia. Eur J Haematol. 2014; 93(2): 103-111.Buxhofer-AuschVOlcayduDGisslingerBSchallingMFrantalSThieleJDecanucleotide insertion polymorphism of F7 significantly influences the risk of thrombosis in patients with essential thrombocythemiaEur J Haematol.2014932103111Search in Google Scholar
Bowen DJ, Collins PW. An amino acid polymorphism in von willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13. Blood. 2004; 103(3): 941-947.BowenDJCollinsPW.An amino acid polymorphism in von willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13Blood.20041033941947Search in Google Scholar
van ’t Hooft FM, Silveira A, Tornvall P, Iliadou A, Ehrenborg E, Eriksson P, et al. Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration. Blood. 1999; 93(10): 3432-3441.van’t HooftFMSilveiraATornvallPIliadouAEhrenborgEErikssonPTwo common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentrationBlood.1999931034323441Search in Google Scholar
Croft SA, Samani NJ, Teare MD, Hampton KK, Steeds RP, Channer KS, et al. Novel platelet membrane glycoprotein VI dimorphism is a risk factor for myocardial infarction. Circulation. 2001; 104(13): 1459-1463.CroftSASamaniNJTeareMDHamptonKKSteedsRPChannerKSNovel platelet membrane glycoprotein VI dimorphism is a risk factor for myocardial infarctionCirculation.20011041314591463Search in Google Scholar
Pina-Cabral LB, Carvalhais V, Mesquita B, Escór-cio C, Salgado P, Santos A, et al. Allelic and genotypic frequencies of platelet glycoprotein polymorphisms in a portuguese population. Rev Port Cardiol. 2013; 32(2): 111-115.Pina-CabralLBCarvalhaisVMesquitaBEscór-cioCSalgadoPSantosAAllelic and genotypic frequencies of platelet glycoprotein polymorphisms in a portuguese populationRev Port Cardiol.2013322111115Search in Google Scholar
Jimenez S, Tassies D, Espinosa G, Garcķa-Criado A, Plaza J, Monteagudo J, et al. Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus. Ann Rheum Dis. 2008; 67(6): 835-840.JimenezSTassiesDEspinosaGGarcķa-CriadoAPlazaJMonteagudoJDouble heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosusAnn Rheum Dis.2008676835840Search in Google Scholar
Yonal I, Hindilerden F, Hancer VS, Artim-Esen B, Daglar A, Akadam B, et al. The impact of platelet membrane glycoprotein ib alpha and Ia/IIa polymorphisms on the risk of thrombosis in the antiphospholipid syndrome. Thromb Res. 2012; 129(4): 486-491.YonalIHindilerdenFHancerVSArtim-EsenBDaglarAAkadamBThe impact of platelet membrane glycoprotein ib alpha and Ia/IIa polymorphisms on the risk of thrombosis in the antiphospholipid syndromeThromb Res.20121294486491Search in Google Scholar
Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, et al. Seven haemostatic gene polymorphisms in coronary disease: Meta-analysis of 66,155 cases and 91,307 controls. Lancet. 2006; 367(9511): 651-658.YeZLiuEHHigginsJPKeavneyBDLoweGDCollinsRSeven haemostatic gene polymorphisms in coronary disease: Meta-analysis of 66,155 cases and 91,307 controlsLancet.20063679511651658Search in Google Scholar
Hoppe B, Tolou F, Dorner T, Kiesewetter H, Salama A. Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: Frequency distribution in a healthy german population. Thromb Haemost. 2006; 96(4): 465-470.HoppeBTolouFDornerTKiesewetterHSalamaA.Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: Frequency distribution in a healthy german populationThromb Haemost.2006964465470Search in Google Scholar
Zhang LJ, Li HH, Tao SB, Yuan B, Yan HQ, Chang L, et al. FGB gene - 148C>T polymorphism is associated with increased risk of ischemic stroke in a Chinese population: A meta-analysis based on 18 case-control studies. Genet Test Mol Biomarkers. 2014; 18(6): 377-382.ZhangLJLiHHTaoSBYuanBYanHQChangLFGB gene - 148C>T polymorphism is associated with increased risk of ischemic stroke in a Chinese population: A meta-analysis based on 18 case-control studiesGenet Test Mol Biomarkers.2014186377382Search in Google Scholar
Zhang X, Li Y, Guo X, Du L, Ma J. Relationship between the -455G/A and -148C/T polymorphisms in the β-fibrinogen gene and cerebral infarction in the Xinjiang Uygur and Han Chinese populations. Neural Regen Res. 2012; 7(7): 546-551.ZhangXLiYGuoXDuLMaJ.Relationship between the -455G/A and -148C/T polymorphisms in the β-fibrinogen gene and cerebral infarction in the Xinjiang Uygur and Han Chinese populationsNeural Regen Res.201277546551Search in Google Scholar
Liang L, Sun C, Xiao F, Tang XL, Chen XD, Zhou DF, et al. (See above) Nine polymorphisms of fibrinogen gene and their association with plasma fibrinogen levels in Hainan Han population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005; 22(4): 457-461.PAGELiangLSunCXiaoFTangXLChenXDZhouDF(See above) Nine polymorphisms of fibrinogen gene and their association with plasma fibrinogen levels in Hainan Han populationZhonghua Yi Xue Yi Chuan Xue Za Zhi.2005224457461Search in Google Scholar
Carobbio A, Thiele J, Passamonti F, Rumi E, Ruggeri M, Rodeghiero F, et al. Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: An international study of 891 patients. Blood. 2011; 117(22): 5857-5859.CarobbioAThieleJPassamontiFRumiERuggeriMRodeghieroFRisk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: An international study of 891 patientsBlood.20111172258575859Search in Google Scholar
Barbui T, Finazzi G, Carobbio A, Thiele J, Passamonti F, Rumi E, et al. Development and validation of an international prognostic score of thrombosis in world health organization-essential thrombocythemia (IPSET-thrombosis). Blood. 2012; 120(26): 5182-5133.BarbuiTFinazziGCarobbioAThieleJPassamontiFRumiEDevelopment and validation of an international prognostic score of thrombosis in world health organization-essential thrombocythemia (IPSET-thrombosis)Blood20121202651825133Search in Google Scholar
Dahlback B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA. 1994; 91(4): 1396-1400.DahlbackBHildebrandB.Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA.199491413961400Search in Google Scholar
Ruggeri M, Gisslinger H, Tosetto A, Rintelen C, Mannhalter C, Pabinger I, et al. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia. Am J Hematol. 2002; 71(1): 1-6.RuggeriMGisslingerHTosettoARintelenCMannhalterCPabingerIFactor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemiaAm J Hematol.200271116Search in Google Scholar
Schwarz J, Ovesná P, Černá O, Kissová J, Maaloufová Soukupová J, Brychtová Y, et al.; CZEMP-Czech Group for Ph-Myeloproliferative Disorders. Thrombosis in thrombocythemic Ph- myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry of patients treated with anagrelide. Eur J Haematol. 2016; 96(1): 98-106.SchwarzJOvesnáPČernáOKissováJMaaloufová SoukupováJBrychtováYCZEMP-Czech Group for Ph-Myeloproliferative Disorders. Thrombosis in thrombocythemic Ph- myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry of patients treated with anagrelideEur J Haematol.201696198106Search in Google Scholar
De Stefano V, Za T, Rossi E, Fiorini A, Ciminello A, Luzzi C, et al. Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia. Haematologica. 2009; 94(5): 733-737.De StefanoVZaTRossiEFioriniACiminelloALuzziCInfluence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemiaHaematologica.2009945733737Search in Google Scholar
Tevet M, Ionescu R, Dragan C, Lupu AR. Influence of the JAK2 V617F Mutation and inherited thrombophilia on the thrombotic risk among patients with myelo-roliferative disorders. Maedica (Buchar). 2015; 10(1): 27-32.TevetMIonescuRDraganCLupuAR.Influence of the JAK2 V617F Mutation and inherited thrombophilia on the thrombotic risk among patients with myelo-roliferative disordersMaedica (Buchar).20151012732Search in Google Scholar